BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17577124)

  • 21. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
    Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
    Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon.
    Dzoyem JP; Kechia FA; Ngaba GP; Lunga PK; Lohoue PJ
    Afr Health Sci; 2012 Jun; 12(2):129-33. PubMed ID: 23056017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
    Deiss R; Loreti CV; Gutierrez AG; Filipe E; Tatia M; Issufo S; Ciglenecki I; Loarec A; Vivaldo H; Barra C; Siufi C; Molfino L; Tamayo Antabak N
    PLoS One; 2021; 16(4):e0250195. PubMed ID: 33901215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
    Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
    Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.
    Ferreira MF; Brito-Santos F; Trilles L; Almeida MA; Wanke B; Veloso VG; Nunes EP; Lazera MDS
    Mycoses; 2020 Feb; 63(2):145-150. PubMed ID: 31715053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
    Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
    BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should we perform the serum cryptococcal antigen test in people living with HIV hospitalized due to a community-acquired pneumonia episode?
    Silva AP; Zenatti CT; Figueiredo-Mello C; Negra MD; Levin AS; Boulware DR; Vidal JE
    Int J STD AIDS; 2020 Mar; 31(4):345-350. PubMed ID: 32089092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and Acceptability of Cryptococcal Antigen Screening and Prevalence of Cryptocococcemia in Patients Attending a Resource-Limited HIV/AIDS Clinic in Malawi.
    Chipungu C; Veltman JA; Jansen P; Chiliko P; Lossa C; Namarika D; Benner B; Hoffman RM; Bristow CC; Klausner JD
    J Int Assoc Provid AIDS Care; 2015; 14(5):387-90. PubMed ID: 26139095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
    French N; Gray K; Watera C; Nakiyingi J; Lugada E; Moore M; Lalloo D; Whitworth JA; Gilks CF
    AIDS; 2002 May; 16(7):1031-8. PubMed ID: 11953469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
    Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
    J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam.
    Dat VQ; Lyss S; Dung NTH; Hung LM; Pals SL; Anh HTV; Kinh NV; Bateganya M
    J Acquir Immune Defic Syndr; 2021 Dec; 88(5):487-496. PubMed ID: 34446679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
    Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
    PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
    Jarvis JN; Lawn SD; Vogt M; Bangani N; Wood R; Harrison TS
    Clin Infect Dis; 2009 Apr; 48(7):856-62. PubMed ID: 19222372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
    Smitson CC; Tenna A; Tsegaye M; Alemu AS; Fekade D; Aseffa A; Blumberg HM; Kempker RR
    PLoS One; 2014; 9(1):e85698. PubMed ID: 24465651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.